Appili Therapeutics Inc APLIF:OTCQX

RT Quote | Exchange | USD
Last | 9:32 AM EST
0.84quote price arrow down-0.0043 (-0.5093%)
Volume
2,202
52 week range
0.57 - 1.37

...

Loading . . .

KEY STATS

  • Open0.84
  • Day High0.84
  • Day Low0.84
  • Prev Close0.8443
  • 52 Week High1.37
  • 52 Week High Date05/20/20
  • 52 Week Low0.57
  • 52 Week Low Date08/28/20
  • Market Cap53.01M
  • Shares Out62.58M
  • 10 Day Average Volume113,947.6
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.15
  • P/E (TTM)-5.76
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Appili Therapeutics Inc News

There is no recent news for this security.

Latest APLIF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Appili Therapeutics Inc is a Canada-based pharmaceutical company. The Company is focused on the acquisition and development of treatments targeting infectious disease. The Company is focused on building and advancing adverse portfolio of anti-infective programs. The Company’s anti-infective portfolio includes ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir. The ATI-2307 is a clinical-stage antifungal candidate in development for severe and difficult-to-treat invasive...
Ian Mortimer
Chairman
Armand Balboni M.D., Ph.D., J.D.
Chief Executive Officer
Kimberly Stephens CPA
Chief Financial Officer
Address
#21-1344 Summer Street
Halifax, NS
B3H 0A8
Canada